The unprecedented statistical power of such large datasets enabled confirmation that protein-truncating variants (PTVs) in BRCA1, BRCA2, PALB2 and the Li-Fraumeni syndrome gene TP53 confer high risk for breast cancer. The gene discussed is BRCA2; the disease is breast carcinoma.